Management's credibility is gone.This company is entering a death spiral.No one will believe a word they say. Farmouts will be extremely difficult. Raising working capital will be even more difficult.This company is now "seriously damaged goods".
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%